Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Antin

Showing results (51-60 of 119) with videos related to

Pageof 12
Sort By:
Annals of Internal Medicine|August 15, 1988
Reversal of infection with Mycobacterium avium intracellulare by treatment with alpha-interferon in a patient with hairy cell leukemiaR T Maziarz, I Tepler, J H Antin, et al.
Bone Marrow Transplantation|March 29, 2002
A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantationJ H Antin, S J Lee, D Neuberg, et al.
Blood|December 1, 1991
Lymphokine profile in bone marrow transplant recipientsL C Schneider, J H Antin, H Weinstein, et al.
Blood|January 1, 1987
Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia?M A Goldberg, D Ginsburg, R J Mayer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 28, 1999
Long-term follow-up of patients who achieved complete remission after donor leukocyte infusionsD L Porter, R H Collins, O Shpilberg, et al.
Bone Marrow Transplantation|July 5, 2006
Quality of life associated with acute and chronic graft-versus-host diseaseS J Lee, H T Kim, V T Ho, et al.
AJR. American Journal of Roentgenology|September 1, 1995
Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 casesR B Schwartz, S M Bravo, R A Klufas, et al.
Blood|February 7, 2001
A double-blind, placebo-controlled trial of pegylated recombinant human megakaryocyte growth and development factor as an adjunct to induction and consolidation therapy for patients with acute myeloid leukemiaC A Schiffer, K Miller, R A Larson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Improved survival for patients with acute myelogenous leukemiaA J Mitus, K B Miller, D P Schenkein, et al.
Blood|December 1, 1989
Monoclonal and oligoclonal gammopathy after bone marrow transplantationA J Mitus, R Stein, J M Rappeport, et al.
Pageof 12

Showing results (51-60 of 119) with videos related to

Sort By:
Pageof 12
Annals of Internal Medicine|August 15, 1988
Reversal of infection with Mycobacterium avium intracellulare by treatment with alpha-interferon in a patient with hairy cell leukemiaR T Maziarz, I Tepler, J H Antin, et al.
Bone Marrow Transplantation|March 29, 2002
A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantationJ H Antin, S J Lee, D Neuberg, et al.
Blood|December 1, 1991
Lymphokine profile in bone marrow transplant recipientsL C Schneider, J H Antin, H Weinstein, et al.
Blood|January 1, 1987
Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia?M A Goldberg, D Ginsburg, R J Mayer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 28, 1999
Long-term follow-up of patients who achieved complete remission after donor leukocyte infusionsD L Porter, R H Collins, O Shpilberg, et al.
Bone Marrow Transplantation|July 5, 2006
Quality of life associated with acute and chronic graft-versus-host diseaseS J Lee, H T Kim, V T Ho, et al.
AJR. American Journal of Roentgenology|September 1, 1995
Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 casesR B Schwartz, S M Bravo, R A Klufas, et al.
Blood|February 7, 2001
A double-blind, placebo-controlled trial of pegylated recombinant human megakaryocyte growth and development factor as an adjunct to induction and consolidation therapy for patients with acute myeloid leukemiaC A Schiffer, K Miller, R A Larson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Improved survival for patients with acute myelogenous leukemiaA J Mitus, K B Miller, D P Schenkein, et al.
Blood|December 1, 1989
Monoclonal and oligoclonal gammopathy after bone marrow transplantationA J Mitus, R Stein, J M Rappeport, et al.
Pageof 12